Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Allianz Real Estate in connection with a joint venture with Heimstaden Bostad
Mandate

Vinge has advised Allianz Real Estate in connection with a joint venture with Heimstaden Bostad

January 31, 2022 Real Estate and Construction M&A Banking and Finance

Vinge has assisted Allianz Real Estate in connection with an investment of SEK 7.9 billion in Heimstaden Bostad’s Swedish portfolio, which was recently acquired from Akelius, through the formation of a joint venture. The portfolio consists of centrally located properties in Malmö and Stockholm with a value of SEK 30.4 billion.

Vinge’s team consisted of Assur Badur, Karolina Cohrs and Frida Ställborn (Real Estate), Joacim Rydergård and Clara Sohlberg (Private M&A), and Mikael Ståhl and Arvid Weimers (financing).

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025